BCL2 and non-small cell lung carcinoma: In contrast to the control group and cells treated with either sorafenib or dauricine alone, this study indicated that NSCLC cells injected with sorafenib and dauricine combo exhibited a marked drop in Bcl2 values, a protein that inhibits apoptosis.